D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
PUT
Halliburton
HAL
$26.1B
| $23.4M | 0.02% |
1,146,800
+173,100
| +18% | +$3.63M |
|
877
Atour Lifestyle Holdings
ATAT
$4.81B
| $23.4M | 0.02% |
718,347
+183,012
| +34% | +$5.2M |
|
878
Devon Energy
DVN
$51.3B
| $23.3M | 0.02% |
733,959
-85,498
| -10% | -$2.72M |
|
879
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.14B
| $23.2M | 0.02% |
355,661
-113,800
| -24% | -$7.25M |
|
880
PUT
Dow Inc
DOW
$22B
| $23.2M | 0.02% |
877,000
+171,600
| +24% | +$4.99M |
|
|
AXON
881
CALL
Axon Enterprise
AXON
$42.8B
| $23.2M | 0.02% |
28,000
-500
| -2% | -$340K |
|
882
Warby Parker
WRBY
$3.19B
| $23.1M | 0.02% |
1,055,580
-723,283
| -41% | -$13.4M |
|
883
State Street
STT
$48.4B
| $23.1M | 0.02% |
217,652
-30,708
| -12% | -$2.84M |
|
884
CALL
Bristol-Myers Squibb
BMY
$129B
| $23.1M | 0.02% |
500,000
+184,700
| +59% | +$9.07M |
|
885
Church & Dwight Co
CHD
$23.7B
| $23.1M | 0.02% |
240,598
+40,700
| +20% | +$4.01M |
|
886
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
| $23.1M | 0.02% |
+171,536
| New | +$23.2M |
|
|
NAGE
887
Niagen Bioscience
NAGE
$256M
| $23.1M | 0.02% |
1,601,808
+318,018
| +25% | +$3.14M |
|
888
CALL
Nutrien
NTR
$33.9B
| $23.1M | 0.02% |
395,800
| – | – |
|
889
Ambev
ABEV
$47.9B
| $23M | 0.02% |
9,525,015
+6,301,204
| +195% | +$15.3M |
|
890
ICF International
ICFI
$1.5B
| $22.9M | 0.02% |
270,708
+89,098
| +49% | +$7.55M |
|
891
Prestige Consumer Healthcare
PBH
$2.47B
| $22.9M | 0.02% |
286,608
+89,415
| +45% | +$7.48M |
|
892
VanEck Semiconductor ETF
SMH
$60.8B
| $22.9M | 0.02% |
82,035
+14,482
| +21% | +$3.36M |
|
893
Steris
STE
$22.9B
| $22.9M | 0.02% |
95,156
-14,955
| -14% | -$3.48M |
|
894
CALL
Electronic Arts
EA
$52.4B
| $22.8M | 0.02% |
+142,800
| New | +$21.1M |
|
895
FuboTV Inc
FUBO
$260M
| $22.8M | 0.02% |
491,225
-521,286
| -51% | -$19.5M |
|
896
PUT
Pinterest
PINS
$13.7B
| $22.7M | 0.02% |
633,000
+295,000
| +87% | +$8.95M |
|
897
CALL
Upstart Holdings
UPST
$2.55B
| $22.7M | 0.02% |
350,700
-92,000
| -21% | -$4.51M |
|
898
Pediatrix Medical
MD
$2.2B
| $22.6M | 0.02% |
1,577,762
-294,415
| -16% | -$4.04M |
|
899
Valmont Industries
VMI
$8.86B
| $22.5M | 0.02% |
68,747
-61,764
| -47% | -$18.9M |
|
900
MGIC Investment
MTG
$6.47B
| $22.4M | 0.02% |
805,391
+478,675
| +147% | +$12.3M |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.